| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0086 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |